Yarema Kristin
SEC insider (Form 3/4/5 filer). CIK 0001803794. Chief Executive Officer at ImageneBio, Inc. (IMA) and 1 other issuer. 9 reported Form 4/5 transactions since Sep 2024; latest on Aug 14, 2026. Located in SAN DIEGO, CA.
Companies Yarema Kristin has filed insider reports for
- ImageneBio, Inc. (IMA): Director, Officer, Chief Executive Officer
- Poseida Therapeutics, Inc. (PSTX): Officer, President and CEO
Yarema Kristin
CIK: 0001803794
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Aug 14, 2026IMA
ImageneBio, Inc.
AwardDirect254.8K shares- - Jul 25, 2026IMA
ImageneBio, Inc.
ExerciseDirect38.4K shares- - Jul 25, 2026IMA
ImageneBio, Inc.
OtherDirect115.1K shares- - Mar 16, 2026IMA
ImageneBio, Inc.
AwardDirect85.4K shares- - Jul 28, 2025IMA
ImageneBio, Inc.
AwardDirectRestricted Stock Units
153.5K shares- - Jul 28, 2025IMA
ImageneBio, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
460.5K shares- - Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
DispositionDirectEmployee Stock Option (Right to Buy)
345.2K shares- - Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
Tender OfferDirect615.8K shares- - Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
DispositionDirectEmployee Stock Option (Right to Buy)
498.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 14, 2026 |  IMA ImageneBio, Inc. | Award | 254,800 | - | $0 | Direct |
| Jul 25, 2026 | IMA ImageneBio, Inc. | Exercise | 38,376 | - | $0 | Direct |
| Jul 25, 2026 | IMA ImageneBio, Inc. | Other | 115,129 | - | $0 | Direct |
| Mar 16, 2026 | IMA ImageneBio, Inc. | Award | 85,400 | - | $0 | Direct |
| Jul 28, 2025 | IMA ImageneBio, Inc. | Award Restricted Stock Units | 153,505 | - | - | Direct |
| Jul 28, 2025 | IMA ImageneBio, Inc. | Award Employee Stock Option (Right to Buy) | 460,515 | - | - | Direct |
| Jan 8, 2025 |  PSTX Poseida Therapeutics, Inc. | Disposition Employee Stock Option (Right to Buy) | 345,200 | - | - | Direct |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | Tender Offer | 615,836 | - | $0 | Direct |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | Disposition Employee Stock Option (Right to Buy) | 498,325 | - | - | Direct |
1-9 of 9 transactions